GEMTUZUMAB OZOGAMICIN | B761060 | WYETH PHARMS INC
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Sep. 1, 2029 | Active | Computed |
| 7-Year Orphan | Sep. 1, 2024 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12398402(method of use) · relevance 80/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
4 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.